The negative impact of opioids on those who misuse them has been widely documented.
Despite significant spillover effects in the form of elevated rates of child maltreatment and …

Objectives Neonatal abstinence syndrome (NAS) is a combination of symptoms in infants
exposed to any variety of substances in utero. Information systems and registries help to …

Neonatal abstinence syndrome (NAS) is a postnatal withdrawal syndrome among neonates
born to mothers with drug dependence disorders. NAS poses a significant public health …

Purpose Accurate ascertainment of gestational age (GA) has been a challenge in perinatal
epidemiologic research. To date, no study has validated GA algorithms in Medicaid Analytic …

Infants in drug withdrawal have complex physiological and behavioral states, requiring
intensive nursing care. The study objectives were to describe acuity, parental needs, and …

Background: Musculoskeletal changes occur during pregnancy; one-half of pregnant
women experienced low back pain and/or pelvic pain during pregnancy. Prescription opioid …

Background Morbidity and mortality attributed to prescription opioids are a crisis in the US
and spreading globally. Sex differences related to these conditions have not been …

Background Most studies examining the relationship between neonatal abstinence
syndrome (NAS) and health insurance status in the United States (USA) have used …

Background Despite the rising incidence of neonatal abstinence syndrome (NAS), data
evaluating trends in maternal risk factors associated with NAS have not been available for …

Objective To increase the usage rate of mothers' own milk (MOM) among neonates with
prenatal opioid exposure from a baseline average of 47% to an average of 75% over two …